Insider Selling: Heartflow (NASDAQ:HTFL) CEO Sells 35,010 Shares

Key Points

• Heartflow CEO John Farquhar sold 35,010 shares at an average price of $46.42, generating approximately $1.63 million. The transaction was made under a pre-arranged Rule 10b5-1 plan and reduced his direct holdings by 9.7% to 325,804 shares.
• Heartflow shares recently traded at $49.54, near their 52-week high of $51.78, with a market capitalization of approximately $4.31 billion. The company remains unprofitable but reported quarterly revenue growth of 47.7% and beat analysts’ EPS expectations.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $44.88, below the stock’s reported trading price.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CEO John Farquhar sold 35,010 shares of the stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $46.42, for a total value of $1,625,164.20. Following the sale, the chief executive officer directly owned 325,804 shares in the company, valued at $15,123,821.68. This represents a 9.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Friday, September 11th, John Farquhar sold 3,890 shares of Heartflow stock. The shares were sold at an average price of $50.00, for a total value of $194,500.00.
• On Friday, August 21st, John Farquhar sold 27,230 shares of Heartflow stock. The shares were sold at an average price of $50.00, for a total value of $1,361,500.00.
• On Tuesday, August 18th, John Farquhar sold 32,676 shares of Heartflow stock. The stock was sold at an average price of $45.00, for a total value of $1,470,420.00.
• On Friday, August 14th, John Farquhar sold 15,560 shares of Heartflow stock. The shares were sold at an average price of $39.06, for a total value of $607,773.60.
• On Monday, August 10th, John Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $28.31, for a total transaction of $638,730.22.
• On Friday, July 10th, John Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $27.75, for a total transaction of $626,095.50.
• On Wednesday, June 24th, John Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00.

Heartflow Stock Performance

Shares of NASDAQ HTFL traded down $0.34 during trading hours on Monday, hitting $49.54. 1,619,526 shares of the stock were exchanged, compared to its average volume of 1,556,569. The company's fifty day simple moving average is $35.52 and its two-hundred day simple moving average is $30.84. The company has a market cap of $4.31 billion and a PE ratio of -27.07. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $51.78.

Heartflow (NASDAQ:HTFL - Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. The business had revenue of $64.08 million during the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business's quarterly revenue was up 47.7% compared to the same quarter last year. As a group, sell-side analysts expect that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. JPMorgan Chase & Co. raised their price objective on Heartflow from $35.00 to $45.00 and gave the company an "overweight" rating in a research note on Friday, August 14th. Canaccord Genuity Group increased their target price on shares of Heartflow from $37.00 to $45.00 and gave the stock a "buy" rating in a report on Friday, August 14th. Morgan Stanley raised their price target on shares of Heartflow from $35.00 to $40.00 and gave the company an "equal weight" rating in a research note on Friday, August 14th. Freedom Capital raised shares of Heartflow to a "strong-buy" rating in a report on Tuesday, June 30th. Finally, Weiss Ratings raised shares of Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $44.88.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in HTFL. XXEC Inc. bought a new stake in Heartflow during the 2nd quarter worth approximately $2,524,764,000. BlackRock Inc. bought a new position in shares of Heartflow during the second quarter valued at $152,502,000. Bamco Inc. NY acquired a new position in shares of Heartflow during the second quarter worth $94,625,000. Jupiter Topco LLC bought a new stake in shares of Heartflow in the second quarter worth $70,983,000. Finally, Janus Henderson Group PLC increased its holdings in Heartflow by 152.0% in the first quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company's stock valued at $53,063,000 after purchasing an additional 1,315,416 shares during the period.

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient's coronary arteries.

The company's primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.